Optimization of multiplex PCR composition to screen for SARS-CoV-2 variants of concern
Abstract
Background: The ongoing COVID-19 pandemic has led to the emergence of several variants of concern. To rapidly identify those variants, screening samples for whole-genome sequencing (WGS) prioritization could be performed.
Objective: We optimized the polymerase chain reaction (PCR) screening method to identify the mutation in spike and ORF1a regions.
Methods: We adopted primers targeting mutation in spike and ORF1a region from another study. We optimized the PCR screening method using kits readily available in Indonesia. Firstly, we compared N1 and N2 primers as internal positive control. We also compared GoTaq® 1-Step RT-qPCR System and Indonesia TFRIC-19 BioCOV-19 for the multiplex reaction. We used the optimized composition to screen SARS-CoV-2 positive samples from April – June 2021. Samples with spike and/or ORF1a target failure were subjected to whole genome sequencing (WGS).
Results: The results demonstrated the N2 BioCOV-19 reaction as the optimized multiplex PCR composition for spike and ORF1a mutations screening. Whole-genome sequencing has shown that a sample with spike and ORF1a targets failure to be Alpha variant, while other samples with single target failure as non-variants of concern. Therefore, a multiplex RT-PCR composition has been optimized to detect mutation in spike and ORF1a regions.
Conclusion: We have optimized a multiplex RT-PCR composition to detect mutation in spike and ORF1a regions.
References
Khateeb J, Li Y, Zhang H. Emerging SARS-CoV-2 variants of concern and potential intervention approaches. Crit Care. 2021;25: 244. https://doi.org/10.1186/s13054-021-03662-x
Kalia K, Saberwal G, Sharma G. The lag in SARS-CoV-2 genome submissions to GISAID. Nat Biotechnol. 2021;39: 1058-1060. https://doi.org/10.1038/s41587-021-01040-0
Bal A, Destras G, Gaymard A, Stefic K, Marlet J, Eymieux S, et al. Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69-V70, France, August to December 2020. Euro Surveill. 2021;26. https://doi.org/10.2807/1560-7917.ES.2021.26.3.2100008
Vogels CBF, Breban MI, Ott IM, Alpert T, Petrone ME, Watkins AE, et al. Multiplex qPCR discriminates variants of concern to enhance global surveillance of SARS-CoV-2. PLoS Biol. 2021;19: e3001236. https://doi.org/10.1371/journal.pbio.3001236
Cahyani I, Putro EW, Ridwanuloh AM, Wibowo SHB, Hariyatun H, Syahputra G, et al. Genome Profiling of SARS-CoV-2 in Indonesia, ASEAN, and the Neighbouring East Asian Countries: Features, Challenges, and Achievements. BioRxiv. 2021; https://doi.org/10.1101/2021.07.06.451270
Brejová B, Boršová K, Hodorová V, Čabanová V, Reizigová L, Paul ED, et al. A SARS-CoV-2 mutant from B.1.258 lineage with ∆H69/∆V70 deletion in the Spike protein circulating in Central Europe in the fall 2020. Virus Genes. 2021;57: 556-560. https://doi.org/10.1007/s11262-021-01866-5
Meng B, Kemp SA, Papa G, Datir R, Ferreira IATM, Marelli S, et al. Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7. Cell Rep. 2021;35: 109292. https://doi.org/10.1016/j.celrep.2021.109292
TaqMan SNP genotyping | BIONUMERICS [Internet]. [cited 29 Dec 2021]. Available: https://www.applied-maths.com/applications/taqman-based-snp-genotyping
Zaqy EA, Elgebaly HH, Adly AA, Atia FM, Ahmed RZ. Interleukin 2 receptor Alfa gene polymorphism in type 1 Egyptian diabetics. Current Pediatric Research. 2018;22: 38-49.
Woo HG, Shah M. Omicron: A heavily mutated SARS-CoV-2 variant exhibits stronger binding to ACE2 and potently escape approved COVID-19 therapeutic antibodies. BioRxiv. 2021; https://doi.org/10.1101/2021.12.04.471200
Copyright (c) 2021 Authors
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
